Reportlinker Adds The Top 10 Orthopedic Device Companies: Financial performance, research activities, and growth strategies
NEW YORK, Sept. 7 /PRNewswire/ --Reportlinker.com announces that a new market research report is available in its catalogue:
The orthopedic device industry is highly competitive and has reached maturity, as demonstrated by its single digit growth rate. The industry is driven largely by incremental innovation and breakthrough product launches have stalled. Several product lines are also facing severe commoditization due to increased competition. Despite such high levels of competition, the top 15 companies accounted for 95% of the market in 2009. The largest device segments are spinal, knee, and hip implants. The fastest growing segment is orthobiologics.
The report provides detailed profiles of the top 10 orthopedic device companies and brief profiles of five other major players. It elucidates trends associated with companies that develop, manufacture, and market orthopedic devices. Detailed profiles contain descriptions of products, financial performance, and growth strategies together with SWOT analyses. For each company analysis is based on:
- Each company's consolidated and segmental financial performance;
- Each company's growth strategies and major acquisitions and divestments relating to the CV devices market;
- Key partnerships and alliances formed by these companies;
- Business-related strengths and weaknesses of these companies, and insights into the opportunities and threats facing them.
Key drivers and resistors to growth of leading CV device companies.
Drivers
- Demographics – aging population
- Preference for biologic implants increasing
- Growth in emerging markets
- Physician preferences boosted by CME programs
- Continued innovation
Resistors
- Increasing pricing pressure from buyers and payers
- Rising usage of comparative efficacy and health economics data
- Regulatory demand for postmarketing surveillance
- Review of the PMN pathway in the US
- Medical device excise tax amounting to $20bn over the next 20 years
Key benefits of reading this report
- Learn from the business operation strategies of the premier orthopedic device companies to target future growth markets effectively, avoid their mistakes, and replicate their successes.
- Benchmark your performance against the leading orthopedic device companies.
- Analyze the growth strategies of major players in the orthopedic industry and learn how their business models are planned for the next 3 to 5 years .
- Compare performances of the top 10 companies in the orthopedic market with respect to acquisitions, new product innovation, geography expansion, and industry challenges.
- Save time, money, and resources on analyzing the performance of leading orthopedic device companies using this report.
Key findings from this report
- The global orthopedic market had an estimated $33bn size in 2009, a Y-o-Y increase of 7.1%. The market is moderately dependent on macroeconomic trends and demographics.
- In 2009, the market growth was adversely affected by patient deferral of orthopedic procedures and increased pricing pressure from buyers. Market performance was also considerably impacted by currency fluctuations, owing to a strengthening US dollar. This is due to the fact that majority of orthopedic companies are based in the US.
- Spine, knee, and hip implants formed the largest orthopedic market segments in 2009, and accounted for nearly $18.2bn sales. Surgical accessories used in orthopedic procedures represent the most fragmented market segment, followed by spinal devices. The orthobiologics segment has the least competition and was also fastest growing segment.
- Regulatory pressure on the orthopedic market will significantly rise due to the impending review of the PMN pathway, the Physician Payment Sunshine Act and application of comparative effectiveness research (CER) information by buyers and payers.
- Along with CER studies, the impending $20bn medical device tax will add further pricing pressures.
Key questions answered by this report
- What was the market value of the global orthopedic device industry in 2009?
- What are the global market values for the major orthopedic device segments?
- What are the key trends observed in the orthopedic device companies and what are the strategic responses that are taking shape?
- Who are the major players in the global orthopedic device market?
- What are the growth strategies of the leading orthopedic device companies?
- What are the strengths, weaknesses, opportunities and threats faced by the top 10 players?
Table of Contents
About Business Insights 2
Disclaimer 2
Executive summary 11
Industry overview 11
Stryker 11
DePuy 12
Zimmer 12
Medtronic 13
Synthes 13
Smith & Nephew 14
Biomet 14
Orthofix 14
Wright Medical Group 15
Conmed 15
Chapter 1 Introduction 17
What is this report about? 17
Methodology 17
Chapter 2 Industry overview 18
Summary 18
Introduction 18
Market segmentation 20
Competitive landscape 21
Key drivers and resistors 22
Key events and trends 23
Changes in the PMN pathway will increase regulatory burden 23
CME platforms will continue to drive growth despite the Department of Justice (DOJ) clampdown 24
CME and inducements 24
DOJ settlement with device manufacturers 25
Physician Sunshine Act may stifle innovation in the orthopedic device industry 27
Impact of decline in hospital capital expenditure on orthopedics minimal in the near term 28
Medical device industry bracing for the comparative effectiveness research (CER) era 29
Medical device excise tax will influence orthopedic market top line 30
Rising regulatory pressure on spinal device makers 30
Chapter 3 Stryker 31
Summary 31
Company overview 31
Marketed products 32
Orthopedic implants 32
MedSurg equipment 32
Financial performance 32
Orthopedic implants 34
Hip implant systems 34
Knee implant systems 34
Trauma implant systems 34
Spinal implant systems 35
Craniomaxillofacial implant systems 35
MedSurg equipments 35
Surgical equipment and surgical navigation systems 35
Endoscopic and communications systems 35
Research and innovation 36
Growth strategy 36
SWOT 38
Chapter 4 DePuy 39
Summary 39
Company overview 39
Marketed products 40
DePuy Orthopedics 40
DePuy Spine 40
DePuy Mitek 40
Codman & Shurtleff 40
Financial performance 41
Research and product launches 42
Growth strategy 42
SWOT 44
Chapter 5 Zimmer 45
Summary 45
Company overview 45
Marketed products 45
Reconstructive 45
Dental 46
Trauma 46
Spine 46
OSP 46
Financial performance 46
Reconstructive 48
Knee 48
Hip 48
Extremities 49
Dental 49
Trauma 49
Spine 49
OSP 49
Research and innovation 49
Growth strategy 50
SWOT 52
Chapter 6 Medtronic 53
Summary 53
Company overview 53
Marketed products 54
Financial performance 54
Core spinal 55
Biologics 56
Research and innovation 56
Growth strategy 57
SWOT 58
Chapter 7 Synthes 59
Summary 59
Company overview 59
Marketed products 59
Trauma 59
Spine 60
CMF 60
Financial performance 60
Research and innovation 62
Growth strategy 62
SWOT 64
Chapter 8 Smith & Nephew 65
Summary 65
Company overview 65
Marketed products 66
Orthopedics 66
Endoscopy 66
Financial performance 66
Orthopedics 68
Endoscopy 68
Research and innovation 68
Growth strategy 69
SWOT 70
Chapter 9 Biomet 71
Summary 71
Company overview 71
Marketed products 71
Reconstructive products 71
Fixation devices 72
Spinal products 72
Other 72
Financial performance 72
Research and innovation 74
Growth strategy 74
SWOT 76
Chapter 10 Orthofix 77
Summary 77
Company overview 77
Marketed products 78
Spinal products 78
Orthopedic products 78
Sports medicine 78
Financial performance 78
Spine 80
Orthopedics 80
Sports medicine 80
Research and innovation 80
Growth strategies 80
SWOT 82
Chapter 11 Wright Medical Group 83
Summary 83
Company overview 83
Marketed products 83
Hip products 83
Knee products 83
Extremity products 84
Biologics products 84
Financial performance 84
Hip products 86
Knee products 86
Extremity products 86
Biologic products 86
Research and innovation 86
Growth strategy 87
SWOT 88
Chapter 12 Conmed 89
Summary 89
Company overview 89
Marketed products 89
Arthroscopy 89
Powered surgical instruments 90
Financial performance 90
Arthroscopy 92
Powered surgical equipments 92
Research and innovation 92
Growth strategy 92
SWOT 93
Chapter 13 Other major companies 94
NuVasive 94
Integra LifeSciences 95
Arthrocare 96
Exactech 98
RTI Biologics 99
Appendix 101
Abbreviations 101
Table of figures
Figure 1: Orthopedic device global market performance, 2007–09 20
Figure 2: Key drivers and resistors of the orthopedic market 24
Figure 3: Effect of the Physician Payment Sunshine Act on the orthopedic market competitive
landscape 28
Figure 4: Stryker's financial performance, 2007–2009 33
Figure 5: Stryker – SWOT 38
Figure 6: DePuy's financial performance, 2007–2009 42
Figure 7: DePuy – SWOT 44
Figure 8: Zimmer's financial performance, 2007–2009 47
Figure 9: Zimmer – SWOT 52
Figure 10: Financial performance Medtronic's spinal business, 2007–2009 55
Figure 11: Medtronic – SWOT 58
Figure 12: Synthes' financial performance, 2007–2009 61
Figure 13: Synthes – SWOT 64
Figure 14: Smith & Nephew's financial performance, 2007–2009 67
Figure 15: Smith & Nephew – SWOT 70
Figure 16: Biomet's financial performance, 2007–2009 73
Figure 17: Biomet – SWOT 76
Figure 18: Financial performance of Orthofix's orthopedic operations, 2007–2009 79
Figure 19: Orthofix – SWOT 82
Figure 20: Wright Medical Group's financial performance, 2007–2009 85
Figure 21: Wright Medical Group - SWOT 88
Figure 22: Financial performance of Conmed's orthopedic operations, 2007–2009 91
Figure 23: Conmed – SWOT 93
Figure 24: NuVasive's financial performance, 2007–2009 95
Figure 25: Financial performance of Integra LifeScience's orthopedic business, 2007–2009 96
Figure 26: Financial performance of Arthrocare's orthopedic business, 2007–2009 98
Figure 27: Exactech's financial performance, 2007–2009 99
Figure 28: Financial performance of RTI Biologic's orthopedic business, 2007–2009 100
Table of tables
Table 1: Orthopedic device global market performance, 2007–09 19
Table 2: Global market sizes of orthopedic device segments, 2009 21
Table 3: Market shares of top 15 orthopedic device companies, 2007–09 22
Table 4: Orthopedic companies and surgeon/resident training programs 25
Table 5: Settlements by orthopedic players to US DOJ 26
Table 6: Stryker's financial performance, 2007–2009 32
Table 7: Financial performance of Stryker's business units, 2008–2009 34
Table 8: DePuy's financial performance, 2007–2009 41
Table 9: Zimmer's financial performance, 2007–2009 47
Table 10: Financial performance of Zimmer's business units, 2008–2009 48
Table 11: Financial performance Medtronic's spinal business, 2007–2009 54
Table 12: Financial performance of Medtronic's spinal business units, 2008–2009 55
Table 13: Synthes' financial performance, 2007–2009 60
Table 14: Smith & Nephew's financial performance, 2007–2009 66
Table 15: Financial performance of Smith & Nephew's business units, 2008–2009 67
Table 16: Biomet's financial performance, 2007–2009 73
Table 17: Financial performance of Biomet's business units, 2008–09 74
Table 18: Financial performance of Orthofix's orthopedic operations, 2007–2009 78
Table 19: Performance of Orthofix's orthopedic product lines, 2008–2009 79
Table 20: Wright Medical Group's financial performance, 2007–2009 84
Table 21: Performance of Wright Medical Group's orthopedic product lines, 2008-2009 85
Table 22: Financial performance of Conmed's orthopedic operations, 2007–2009 90
Table 23: Performance of Conmed Linvatec's product lines, 2009 91
Table 24: NuVasive's financial performance, 2007–2009 94
Table 25: Financial performance of Integra LifeScience's orthopedic business, 2007–2009 96
Table 26: Financial performance of Arthrocare's orthopedic business, 2007–2009 97
Table 27: Exactech's financial performance, 2007–2009 99
Table 28: Financial performance of RTI Biologic's orthopedic business, 2007–2009 100
To order this report:
Orthopedic Industry: The Top 10 Orthopedic Device Companies: Financial performance, research activities, and growth strategies
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg |
|
Reportlinker |
|
Email: [email protected] |
|
US: (805)652-2626 |
|
Intl: +1 805-652-2626 |
|
SOURCE Reportlinker
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article